Literature DB >> 10359144

Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual.

K Onda1, S Nagai, R Tanaka, K Morii, J I Yoshimura, I Tsumanuma, T Kumanishi.   

Abstract

We established two glioma cell lines from two surgical specimens obtained at different times from the same patient. One (No. 9R), which was derived from the recurrent tumor (glioblastoma, grade IV), proliferated more rapidly in vitro than the other (No. 9) from the primary tumor (slightly anaplastic astrocytoma, grade II-III). No. 9R showed heterotransplantability in nude mice, whereas No. 9 did not. These findings indicate that No. 9R has a more aggressive or malignant nature than No. 9. Both cell lines showed homozygous deletion of the representative tumor suppressor p16 and p15 genes, but no p53 gene alteration. However, examination of the overall mRNA expression profile using a commercially available cDNA-spotted membrane revealed much higher expression levels of several mRNAs, at least, in No. 9R than in No. 9, although the relationship between these mRNAs and the growth potentials remained unknown. These two cell lines, derived from the same individual, with different proliferating potentials may be useful for studies on the molecular bases of glioma malignancy and progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359144     DOI: 10.1023/a:1006172608019

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

2.  Determinants for the establishment of permanent tissue culture lines from human gliomas.

Authors:  B Westermark; J Pontén; R Hugosson
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-11

3.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

4.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

5.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

6.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

7.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

8.  Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.

Authors:  T Mori; K Miura; T Aoki; T Nishihira; S Mori; Y Nakamura
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

9.  CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

Authors:  E E Schmidt; K Ichimura; G Reifenberger; V P Collins
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

10.  A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.

Authors:  S Zhang; S Endo; H Koga; T Ichikawa; X Feng; K Onda; K Washiyama; T Kumanishi
Journal:  Jpn J Cancer Res       Date:  1996-09
View more
  4 in total

1.  Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.

Authors:  Magdalena Ciezka; Milena Acosta; Cristina Herranz; Josep M Canals; Martí Pumarola; Ana Paula Candiota; Carles Arús
Journal:  J Neurooncol       Date:  2016-06-21       Impact factor: 4.130

2.  Inhibition of cellular proliferation and induction of apoptosis by curcumin in human malignant astrocytoma cell lines.

Authors:  Shoichi Nagai; Masanori Kurimoto; Kazuo Washiyama; Yutaka Hirashima; Toshiro Kumanishi; Shunro Endo
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

3.  Establishment and partial characterization of a continuous human malignant glioma cell line: NG97.

Authors:  M C Grippo; P F Penteado; E F Carelli; M A Cruz-Höfling; L Verinaud
Journal:  Cell Mol Neurobiol       Date:  2001-08       Impact factor: 5.046

4.  Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines.

Authors:  Zev A Binder; Kelli M Wilson; Vafi Salmasi; Brent A Orr; Charles G Eberhart; I-Mei Siu; Michael Lim; Jon D Weingart; Alfredo Quinones-Hinojosa; Chetan Bettegowda; Amin B Kassam; Alessandro Olivi; Henry Brem; Gregory J Riggins; Gary L Gallia
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.